Pfizer-Ligand's menopause-symptom drug Duavee wins FDA nod

10/4/2013 | Reuters

Pfizer and Ligand Pharmaceuticals obtained the FDA's approval to market Duavee, a combination of bazedoxifene and conjugated estrogens, for treatment of moderate to severe menopause symptoms and for prevention of post-menopausal osteoporosis. Because of health risks associated with estrogens, the drug will carry a boxed warning.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA